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Aim: To compare the incidences of endophthalmitis after cataract operations before and after 
introduction of intracameral vancomycin at the end of surgery.
Methods: A retrospective analysis was performed of presumed infectious endophthalmitis 
after cataract surgery from January 1, 1998 to December 31, 2008. From January 2001, the 
practice of using intracameral vancomycin at the end of cataract surgery was introduced. The 
period before introduction of intracameral vancomycin is considered as period A and that after 
as period B. The incidences of presumed or culture-proven endophthalmitis during periods 
A and B were compared.
Results: A total of 16,606 cataract surgeries were performed during the study period. The inci-
dence of endophthalmitis per 1000 cataract surgeries was 3.0 during period A and 0.08 during 
period B. This reduction was statistically significantly (Chi-squared test 36.6, P value  0.0001). 
The relative risk of developing endophthalmitis without intracameral vancomycin prophylaxis 
was 38. The absolute risk reduction was 292 cases of endophthalmitis per 100,000 cataract 
surgeries.
Conclusions: Intracameral vancomycin significantly reduced the incidence of postoperative 
endophthalmitis after cataract surgery. There is a universal need to adopt this mode of microbial 
prophylaxis to reduce the burden of endophthalmitis after cataract surgery.
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Introduction
Cataract surgery is the commonest operation performed in health care systems world-
wide. The technique has evolved from extracapsular extraction to sutureless phaco-
emulsification surgery over the past 15 years. Intraocular infection following cataract 
surgery and lens implantation is a rare but dreaded complication that can have devastat-
ing consequences for sight. The Endophthalmitis Vitrectomy Study (EVS) estimated 
that up to half of patients developing endophthalmitis following cataract surgery had 
visual acuity worse than 20/40 and 15% had worse than 5/200.1 The incidence of endo-
phthalmitis following cataract surgery varies between 0.04 and 0.27%.2–4 Even though 
several risk factors have been identified, this complication is often unexpected, with 
variable response to standard treatment. As the number of cataract surgeries is expected 
to rise with an increasing aging population, the burden of endophthalmitis is likely to 
rise. A robust preventative strategy is needed to contain this serious complication. The 
European Society of Cataract and Refractive Surgeons (ESCRS) in a multinational, 
partially-masked placebo-controlled trial have provided strong evidence for using 
intracameral antibiotics in preventing postoperative endophthalmitis following cataract Clinical Ophthalmology 2010:4 322
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surgery.5 In this study we examined the effect of introduction 
of intracameral vancomycin at the end of cataract surgery on 
the incidence of postoperative endophthalmitis in a single 
eye unit in North West England.
Methods
The study included all cataract surgeries performed in the 
Ophthalmic Department at Warrington Hospital in North 
West England from January 1, 1998 to December 31, 2008. 
The standard practice of cataract surgery over this period 
was similar except for the introduction of intracameral van-
comycin at the end of cataract surgery from January 2001. 
In the anesthetic room, 10 minutes prior to cataract surgery, 
each patient had periocular skin cleaning with 5% povidone 
iodine. Two drops of 5% povidone iodine were instilled into 
the conjunctival sac at this stage. The surgeon, after scrubbing 
and draping, used 5% povidone iodine to cleanse the eyelids 
and periocular skin. The eyelids including the eye lashes were 
draped. All cataract surgeries were performed in a dedicated 
ophthalmic theatre assisted by ophthalmic specialist nurses. 
Phacoemulsification was performed either using a peristaltic 
or venturi system. Postoperatively, patients were prescribed 
prednisolone acetate 1% two-hourly for two weeks which was 
then tapered off over a further four weeks. Topical fusidic 
acid was used for 10 days.
However, in 2000, following a cluster of four cases of 
endophthalmitis after cataract surgery during a period of three 
months, the practice of microbial prophylaxis was reviewed. 
Based on evidence existing at the time,1 and following an 
external investigation and extensive discussions with the 
hospital infection control team, a decision was made to use 
vancomycin in a dose of 1 mg in 0.1 mL of normal saline, to 
be injected intracamerally into the capsular bag as the final 
step of cataract surgery.
A case of endophthalmitis was defined as one which 
presented within six weeks of cataract surgery, with typi-
cal clinical findings of intraocular inflammation, reduced 
vision, and with or without culture-positive vitreous biopsy.1 
These cases were entered prospectively into a data col-
lection system. The detection and management of a case 
of endophthalmitis was under the direct supervision of a 
consultant ophthalmologist. All but two cases of suspected 
endophthalmitis had emergency vitreous sampling along 
with intravitreal injection of antibiotics. One case with a 
visual acuity of perception of light, had pars plana vitrectomy 
with intravitreal antibiotics as per EVS study.1 The vitreous 
samples were analyzed according to standard practice, with 
the microbiologist using gram stain and culture on blood agar, 
chocolate agar, and Sabouraud’s agar. Gram stain identified 
Gram-positive or Gram-negative organisms. Aerobic organ-
isms were identified using incubation of blood and chocolate 
agar plates at 35°C for five days. Anaerobic organisms were 
identified by incubation of blood agar plate at 35°C with 
increased carbon dioxide in the atmosphere. Sabouraud’s 
media was incubated at 35°C for 30 days to identify fungal 
organisms. Identified organisms had antibiotic sensitivity 
tests performed to identify susceptibility.
Cases of endophthalmitis following cataract surgery were 
identified from the data collected on the postoperative com-
plication reporting system in the Ophthalmic Department. 
The incidences of endophthalmitis before (period A) and after 
the introduction of intracameral vancomycin after cataract 
surgery (period B) were calculated. The relative risk, relative 
risk reduction, and absolute risk reduction were calculated 
from the data.
Results
A total of 16,606 cataract surgeries with intraocular lens 
implantations were performed between January 1, 1998 
and December 31, 2008. The distribution of cataract sur-
geries over the study period is shown in Figure 1. Between 
January 1, 1998 and December 31, 2000 (period A), prior 
to introduction of intracameral vancomycin, 3904 cataract 
surgeries were performed. Thirteen patients developed 
endophthalmitis during this period. Eleven of the 13 cases of 
endophthamitis had vitreous sampling and intravitreal antibi-
otics and two cases had aqueous sampling and intracameral 
antibiotics. From January 1, 2001 to December 31, 2008 
(period B), 12,702 cataract surgeries were performed using 
intracameral vancomycin at the end of cataract surgery. One 
patient during this period developed presumed endophthal-
mitis with a negative vitreous biopsy.
The incidence of endophthalmitis prior to the introduction 
of intracameral antibiotic prophylaxis was 0.3%. The annual 
incidence of endophthalmitis during the study period is 
shown in Figure 2. After the introduction of intracameral anti-
biotics, the incidence of endophthalmitis dropped to 0.008% 
(Table 1). This reduction was statistically significantly (Chi-
squared test, 36.6; P value  0.0001). The relative risk of 
developing endophthalmitis without intracameral antibiotic 
prophylaxis was 38 (95% confidence interval [CI]: 7–252). 
With the use of intracameral vancomycin, the absolute risk 
reduction was 292 cases of endophthalmitis per 100,000 
cataract surgeries. The relative risk reduction was 97%. Five 
patients with clinical endophthalmitis had a microorgan-
ism identified on gram stain or culture. Eight patients had Clinical Ophthalmology 2010:4 323
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negative gram stain and culture. Three vitreous samples grew 
Streptococcus pneumoniae (Table 2).
The experience of surgeons ranged from consultants with 
more than eight years of experience in performing cataract 
surgery, to middle-grade surgeons with more than four years 
of experience, and to junior-grade surgeons with less than 
four years of experience in performing cataract surgery. The 
incidence of posterior capsular rupture with vitreous loss as 
a complication of cataract surgery was similar over the study 
period at 2.1% during period A and 2.2% during period B. 
Other microbial prophylactic measures including use of 5% 
povidone iodine, and postoperative antibiotics remained 
unchanged in the two periods.
Discussion
Dickey et al have shown that anterior segment intraocular 
surgery frequently introduces bacteria into the anterior 
  chamber.6 In 65% to 100% of healthy subjects, conjunctiva 
and adnexa were found to be colonized by microrganisms 
with the potential to cause endophthalmitis.7,8 The EVS found 
that in 82% of cases of endophthalmitis, the organism isolated 
was the same species as that found in the conjunctiva and lids 
of the same patient.9 In the 420 cases of endophthalmitis in 
the EVS series, 70% of the isolates were coagulase-negative, 
Gram-positive staphylococci. As in the EVS study, our study 
also showed the majority of the culture-positive cases of 
endophthalmitis to be Gram-positive organisms (Table 2).
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Prophylactic measures to reduce postoperative endo-
phthalmitis after cataract surgery are wide and varied. 
Several perioperative and postoperative methods have been 
recognized. Preoperative iodine antisepsis combined with 
preoperative and postoperative topical antibiotic therapy is 
considered the standard of care for this purpose.10 The last 
decade has seen the evolution of intracameral antibiotics as 
a prophylactic measure to prevent postoperative endophthal-
mitis after cataract surgery, claiming superior effectiveness 
compared with standard care. Intracameral antibiotics can 
achieve high concentrations in the anterior chamber but have 
the potential to cause corneal endothelial toxicity. Yoeruek   
et al studied the toxic effects of cefuroxime and vancomycin 
on human corneal endothelial cells, and found them safe in 
clinically used concentrations. Higher concentrations could 
cause irreversible cell death.11
The choice of intracameral antibiotic prophylaxis 
appears to be empirical, based on the fact that the major-
ity of isolates are Gram-positive organisms. The first 
report of intracameral antibiotic prophylaxis was by Pey-
man et al12 using gentamicin. Gimbel reported no case of 
endophthalmitis in a series of 12,000 patients after using 
an infusion fluid of gentamicin together with vancomycin 
during cataract surgery.13 Garat et al in their study used 
intracameral cefazolin because it has a bactericidal effect 
against Gram-positive organisms.14 Montan et al used 
intracameral cefuroxime for microbial prophylaxis after 
cataract surgery for similar reasons. They argued that 
intracameral vancomycin is probably inappropriate due to 
its poor efficacy against gram-positive enterocooci and its 
exclusive capacity to combat infections caused by multire-
sistant Gram-positive bacteria.15 For this reason, the Centers 
for Disease Control and Prevention in the US has cautioned 
against prophylactic vancomycin in cataract surgery.16 Garat 
et al argued that cefazolin might induce less drug resistance 
when compared with cefuroxime. Their choice of cefazolin 
Table 1 Incidence of endophthalmitis before and after introduction 
of intracameral vancomycin prophylaxis
   Cataract  
surgeries
Endophthalmitis  
cases
Incidence 
Period A 1998–2000  
(Preintracameral  
vancomycin)
3904 13 0.3 per 100
Period B 2000–2008  
(Postintracameral  
vancomycin)
12702 
 
1 
 
0.008  
per 100 
Table 2 Characteristics of cases of presumed endophthalmitis after cataract surgery over the 11-year study period
Case 
 
Year 
 
Age 
 
Section 
 
Intraoperative  
complication 
Suture 
 
Onset of  
symptoms 
Intraocular antibiotic 
(Intravitreal or 
intracameral)
Organism on 
gram stain or 
culture
Visual  
acuity at 
last visit
Period A
Case 1 1998 85 Clear corneal Nil Nil 2 days Nil Negative HM
Case 2 1998 80 Scleral tunnel Nil 10.0 nylon 9 days Vancomycin, Ceftazidime Negative 6/12
Case 3 1998 76 Clear corneal Nil Nil 2 days Vancomycin, Ceftazidime Gram-positive 
cocci
6/12
Case 4 1998 85 Scleral tunnel Nil Nil 1 day Gentamicin, Vancomycin Streptococcus 
pneumoniae
No PL
Case 5 1999 91 Scleral tunnel Nil Nil 10 days Vancomycin, Ceftazidime Negative 6/60
Case 6 1999 65 Clear corneal Nil Nil 2 days Cefuroxime, Vancomycin Psuedomonas 
aeruginosa
6/9
Case 7 1999 52 Clear corneal Nil Nil 2 days Teicoplanin, Ciprofloxacin Nil 6/12
Case 8 2000 80 Scleral tunnel Nil Nil 1 day Vancomycin, Ceftazidime Streptococcus 
pneumoniae
No PL
Case 9 2000 69 Clear corneal Nil 10.0 nylon 5 days Teicoplanin, Ciprofloxacin Streptococcus 
pneumonia
6/18
Case 10 2000 75 Scleral tunnel Nil Nil 6 days Cefuroxime, Vancomycin Negative 6/36
Case 11 2000 60 Scleral tunnel Nil Nil 3 days Vancomycin, Ceftazidime Negative 6/9
Case 12 2000 78 Scleral tunnel Nil Nil 14 days Vancomycin, Ceftazidime Negative 6/12
Case 13 2000 93 Scleral tunnel Nil Nil 2 days Vancomycin, Ceftazidime Negative No PL
Period B
Case 14 2008 73 Clear corneal Nil Nil 2 days Vancomycin, Ceftazidime Negative 6/6Clinical Ophthalmology 2010:4 325
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was also based on its cost being 41% less than that of 
cefuroxime.17 The preliminary report of principal results 
from a randomized, partially masked, multicentre study by 
the ESCRS5 provided evidence that the risk of contracting 
endophthalmitis is significantly reduced by an intracameral 
injection of cefuroxime at the end of surgery. The choice 
of intracameral antibiotic in the ESCRS study was based 
on the study by Montan PG et al of the effectiveness and 
safety of cefuroxime.18,19
Our choice of vancomycin in 2000 was guided by the EVS 
and local consultations. Intracameral vancomycin has been 
implicated as a cause of cystoid macular edema. Axer-Siegel 
et al in a randomized controlled trial investigated fluorescein 
angiogram evidence of cystoid macular edema associated 
with use of intracameral vancomycin during extracapsular 
cataract extraction.20 They found a significant increase in 
incidence of cystoid macular edema in the vancomycin 
group compared with the control group. However, design 
flaws, long surgical time, and attrition of patients have raised 
questions about the accuracy of their study results. A more 
recent randomized controlled trial examined the effects of 
intracameral vancomycin and gentamicin on macular thick-
ness as measured by ocular coherence tomography.21 They 
found no statistically significant increase in macular thick-
ness in the group that received intracameral vancomycin 
and gentamicin. In view of the strong evidence in favor of 
intracameral cefuroxime and concerns about the development 
of vancomycin resistance, we are reviewing our choice of 
intracameral antibiotic. With the advent of fourth-generation 
fluoroquinolones, with their superior antibacterial activity, the 
choice of antibiotics in the ESCRS study might be outdated. 
O’Brien et al advocate moxifloxacin as a better choice for 
intracameral antibiotic prophylaxis.22 However, safety studies 
are available only in animal models.
A recent survey23 on antibiotic prophylaxis practice after 
cataract surgery in the UK raises some interesting issues, 
given that 37% of the respondents did not use intracameral 
antibiotic prophylaxis. The practice of the 61% who did 
not respond is unclear. The main criticism of the ESCRS 
study was the lack of a subconjunctival cefuroxime arm. An 
uncontrolled but important study in this context demonstrated 
a threefold reduction in the rate of presumed infectious 
endophthalmitis when prophylactic practice was changed 
from subconjunctival to intracameral cefuroxime injection 
after cataract surgery.24 A 2007 survey of American Society 
of Cataract and Refractive Surgery members found that 77% 
were not using intracameral antibiotics, with the majority 
opting instead for preoperative and postoperative topical 
antibiotics.25 Specifically, fourth-generation fluoroquinolones 
seemed to be a popular option.
We acknowledge that our study has several limitations 
due to its retrospective nature. Wound placement, type of 
intraocular lens, and suture placement are variables that can 
possibly affect development of endophthalmitis. The above 
details were not recorded in most of our patient records. Lack 
of data on these variables could have introduced bias which 
could potential affect the results. A prospective study would 
be required to eliminate such bias.
In summary, there is significant research evidence that 
intracameral antibiotic prophylaxis reduces the incidence of 
endophthalmitis after cataract surgery. Our study, although 
retrospective, with an inherent risk of bias, adds support to this 
body of evidence. The visual, emotional, and financial costs of 
dealing with endophthalmitis following phacoemulsification are 
huge. All ophthalmic surgeons should recognize this potential 
complication and adopt intracameral antibiotics as an essential 
part of intraocular surgery. Until a commercially available, pre-
diluted, single-dose, licensed antibiotic formulation is available, 
arrangements with local hospital pharmacies should be made.
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